| 标题 |
Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:JCO Precision Oncology 作者:Joyce F. Liu; Stéphanie Gaillard; Andrea E. Wahner Hendrickson; Oladapo Yeku; Elisabeth Diver; et al 出版日期:2024-05-17 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)